Search over 3,000 reports

    Non Alcoholic Fatty Liver Disease (NAFLD) - Epidemiology Forecast to 2025

    Non Alcoholic Fatty Liver Disease (NAFLD) - Epidemiology Forecast to 2025
    Date: Dec, 2017
    Type: Pharmaceutical Industry Report
    Pages: 40
    Geography: Global
    Delivery Timeline: 5-7 Business Days
    SKU: DIEI0152
    DelveInsight's "Non Alcoholic Fatty Liver Disease (NAFLD) -Epidemiology Forecast, 2025" provides an overview of the epidemiology trends of Non Alcoholic Fatty Liver Disease (NAFLD) in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Non Alcoholic Fatty Liver Disease (NAFLD). The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical needs associated with the Non Alcoholic Fatty Liver Disease (NAFLD). The report contains the targeted patient populations and the forecast methodology.

    The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by DelveInsight team of industry experts.

    Key Coverage and Benefits

    • The Report includes the prevalent population and how will it change over the next eight years.
    • Coverage of key Non Alcoholic Fatty Liver Disease (NAFLD) sub-populations and its prevalent or incident cases
    • Prevalent or incident cases segmented by age and sex.
    • The key differences in epidemiology patterns across the seven market segments.

    Reasons to buy
    • Developing business strategies by understanding the trends shaping and driving the global Non Alcoholic Fatty Liver Disease (NAFLD) market.
    • Identifying prevalent patient populations as well as risk factors in the global Non Alcoholic Fatty Liver Disease (NAFLD) market will help to improve product design, pricing, and launch plans.
    • Organize sales and marketing efforts by identifying the best opportunities for Non Alcoholic Fatty Liver Disease (NAFLD) therapeutics in each of the markets covered.

    1. Report Introduction
    2. Snapshot of Total Prevalent or Incident cases by 7 MM
    3. Executive Summary
    • Key Findings
    4. Non Alcoholic Fatty Liver Disease (NAFLD) Overview
    • Non Alcoholic Fatty Liver Disease (NAFLD) Definition
    • Pathophysiology
    • Symptoms
    • Etiology
    5. Risk Factors Associated with Non Alcoholic Fatty Liver Disease (NAFLD)
    6. Disease Burden & Unmet Need in the Market
    7. Epidemiology and Patient Populations
    • Key Findings
    • Key Sources used and Forecast Methodology
    • Prevalent Cases and Incident Cases-2015-2025
    • Prevalent & Incident Cases by Category-2015-2025
    • Age-Specific Prevalent/ Incident Cases of Non Alcoholic Fatty Liver Disease (NAFLD)
    • Sex-Specific Prevalent/Incident Cases of Non Alcoholic Fatty Liver Disease (NAFLD)
    • Disease Type Specific Prevalent/Incident Cases of Non Alcoholic Fatty Liver Disease (NAFLD)
    8.Prevalent & Incident Cases by 7 MM-2015-2025
    • Non Alcoholic Fatty Liver Disease (NAFLD) Epidemiology of United States-2025
    • Non Alcoholic Fatty Liver Disease (NAFLD) Epidemiology of United Kingdom-2025
    • Non Alcoholic Fatty Liver Disease (NAFLD) Epidemiology of Germany-2025
    • Non Alcoholic Fatty Liver Disease (NAFLD) Epidemiology of France-2025
    • Non Alcoholic Fatty Liver Disease (NAFLD) Epidemiology of Spain-2025
    • Non Alcoholic Fatty Liver Disease (NAFLD) Epidemiology of Italy-2025
    • Non Alcoholic Fatty Liver Disease (NAFLD) Epidemiology of Japan-2025
    9. Key Takeaways
    10. Appendix
    11.Report Methodology
    12. Consulting Services
    13. Disclaimer
    14. About Us
    Table 1: Clinical subtypes of Indication
    Table 2: Risk Factors
    Table 3: Prevalence cases (%) Region wise
    Table 4: Sources used for forecasting the data
    Table 5: Non Alcoholic Fatty Liver Disease (NAFLD) Global Epidemiology, (2015-2025)
    Table 6: Prevalent Cases of Non Alcoholic Fatty Liver Disease (NAFLD) (Ages =XX Years), US (2015-2025)
    Table 7: Prevalent Cases of Non Alcoholic Fatty Liver Disease (NAFLD) By Sex (Males & Females), US (2015-2025)
    Table 8: Prevalent Cases By Non Alcoholic Fatty Liver Disease (NAFLD) Sub-population, US (2015-2025)
    Table 9: Prevalent Cases of Non Alcoholic Fatty Liver Disease (NAFLD) (Ages =XX Years), United Kingdom (2015-2025)
    Table 10: Prevalent Cases of Non Alcoholic Fatty Liver Disease (NAFLD) By Sex (Males & Females), United Kingdom (2015-2025)
    Table 11: Prevalent Cases By Non Alcoholic Fatty Liver Disease (NAFLD) Sub-population, United Kingdom (2015-2025)
    Table 12: Prevalent Cases of Non Alcoholic Fatty Liver Disease (NAFLD) (Ages =XX Years), Germany (2015-2025)
    Table 13: Prevalent Cases of Non Alcoholic Fatty Liver Disease (NAFLD) By Sex (Males & Females), Germany (2015-2025)
    Table 14: Prevalent Cases By Non Alcoholic Fatty Liver Disease (NAFLD) Sub-population, Germany (2015-2025)
    Table 15: Prevalent Cases of Non Alcoholic Fatty Liver Disease (NAFLD) (Ages =XX Years), France (2015-2025)
    Table 16: Prevalent Cases of Non Alcoholic Fatty Liver Disease (NAFLD) By Sex (Males & Females), France (2015-2025)
    Table 17: Prevalent Cases By Non Alcoholic Fatty Liver Disease (NAFLD) Sub-population, France (2015-2025)
    Table 18: Prevalent Cases of Non Alcoholic Fatty Liver Disease (NAFLD) (Ages =XX Years), Italy (2015-2025)
    Table 19: Prevalent Cases of Non Alcoholic Fatty Liver Disease (NAFLD) By Sex (Males & Females), Italy (2015-2025)
    Table 20: Prevalent Cases By Non Alcoholic Fatty Liver Disease (NAFLD) Sub-population, Italy (2015-2025)
    Table 21: Prevalent Cases of Non Alcoholic Fatty Liver Disease (NAFLD) (Ages =XX Years), Spain (2015-2025)
    Table 22: Prevalent Cases of Non Alcoholic Fatty Liver Disease (NAFLD) By Sex (Males & Females), Spain (2015-2025)
    Table 23: Prevalent Cases By Non Alcoholic Fatty Liver Disease (NAFLD) Sub-population, Spain (2015-2025)
    Table 24: Prevalent Cases of Non Alcoholic Fatty Liver Disease (NAFLD) (Ages =XX Years), Japan (2015-2025)
    Table 25: Prevalent Cases of Non Alcoholic Fatty Liver Disease (NAFLD) By Sex (Males & Females), Japan (2015-2025)
    Table 26: Prevalent Cases By Non Alcoholic Fatty Liver Disease (NAFLD) Sub-population, Japan (2015-2025)
    Figure 1: Prevalence cases (%) Region wise
    Figure 2: Sources used for forecasting the data
    Figure 3: Non Alcoholic Fatty Liver Disease (NAFLD) Global Epidemiology, (2015-2025)
    Figure 4: Prevalent Cases of Non Alcoholic Fatty Liver Disease (NAFLD) (Ages =XX Years), US (2015-2025)
    Figure 5: Prevalent Cases of Non Alcoholic Fatty Liver Disease (NAFLD) By Sex (Males & Females), US (2015-2025)
    Figure 6: Prevalent Cases By Non Alcoholic Fatty Liver Disease (NAFLD) Sub-population,US (2015-2025)
    Figure 7: Prevalent Cases of Non Alcoholic Fatty Liver Disease (NAFLD) (Ages =XX Years), United Kingdom (2015-2025)
    Figure 8: Prevalent Cases of Non Alcoholic Fatty Liver Disease (NAFLD) By Sex (Males & Females), United Kingdom (2015-2025)
    Figure 9: Prevalent Cases By Non Alcoholic Fatty Liver Disease (NAFLD) Sub-population,United Kingdom (2015-2025)
    Figure 10: Prevalent Cases of Non Alcoholic Fatty Liver Disease (NAFLD) (Ages =XX Years), Germany (2015-2025)
    Figure 11: Prevalent Cases of Non Alcoholic Fatty Liver Disease (NAFLD) By Sex (Males & Females), Germany (2015-2025)
    Figure 12: Prevalent Cases By Non Alcoholic Fatty Liver Disease (NAFLD) Sub-population,Germany (2015-2025)
    Figure 13: Prevalent Cases of Non Alcoholic Fatty Liver Disease (NAFLD) (Ages =XX Years), France (2015-2025)
    Figure 14: Prevalent Cases of Non Alcoholic Fatty Liver Disease (NAFLD) By Sex (Males & Females), France (2015-2025)
    Figure 15: Prevalent Cases By Non Alcoholic Fatty Liver Disease (NAFLD) Sub-population,France (2015-2025)
    Figure 16: Prevalent Cases of Non Alcoholic Fatty Liver Disease (NAFLD) (Ages =XX Years), Italy (2015-2025)
    Figure 17: Prevalent Cases of Non Alcoholic Fatty Liver Disease (NAFLD) By Sex (Males & Females), Italy (2015-2025)
    Figure 18: Prevalent Cases By Non Alcoholic Fatty Liver Disease (NAFLD) Sub-population,Italy (2015-2025)
    Figure 19: Prevalent Cases of Non Alcoholic Fatty Liver Disease (NAFLD) (Ages =XX Years), Spain (2015-2025)
    Figure 20: Prevalent Cases of Non Alcoholic Fatty Liver Disease (NAFLD) By Sex (Males & Females), Spain (2015-2025)
    Figure 21: Prevalent Cases By Non Alcoholic Fatty Liver Disease (NAFLD) Sub-population,Spain (2015-2025)
    Figure 22: Prevalent Cases of Non Alcoholic Fatty Liver Disease (NAFLD) (Ages =XX Years), Japan (2015-2025)
    Figure 23: Prevalent Cases of Non Alcoholic Fatty Liver Disease (NAFLD) By Sex (Males & Females), Japan (2015-2025)
    Figure 24: Prevalent Cases By Non Alcoholic Fatty Liver Disease (NAFLD) Sub-population,Japan (2015-2025)
    Non Alcoholic Fatty Liver Disease (NAFLD) Disease Overview

    Non Alcoholic Fatty Liver Disease (NAFLD) Prevalence

    Non Alcoholic Fatty Liver Disease (NAFLD) Incidence

    Non Alcoholic Fatty Liver Disease (NAFLD) Risk Factors

    Non Alcoholic Fatty Liver Disease (NAFLD) Epidemiology

    Non Alcoholic Fatty Liver Disease (NAFLD) Patient Populations

    Non Alcoholic Fatty Liver Disease (NAFLD) Diagnosed Patients

    Non Alcoholic Fatty Liver Disease (NAFLD) Forecast

    Non Alcoholic Fatty Liver Disease (NAFLD) Epidemiology Forecast

    Non Alcoholic Fatty Liver Disease (NAFLD) Treated patients/population

    • Single User License
      (20% Off)
      $2,950.00
    • Site License
      (30% Off)
      $5,900.00
    • Global License
      (40% Off)
      $8,850.00

    Contact Us

    Phone
    +91-11-45689769, +91 9650213330

    Email
    info@delveinsight.com

    Address
    New Delhi-110075, India

    Latest Tweets

    • Copyright © 2017 Delveinsight.
    • Sitemap